chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: rash on her upper left thigh; doctor said her rash looked like Shingles; rash was itchy in the beginning with little blisters; rash was itchy in the beginning with little blisters; rash was just a bothersome discomfort; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 11Mar2021 (Batch/Lot Number: EN6206; Expiration Date: 30Mar2021) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient took her first COVID-19 Vaccine dose on 11Mar2021. She said she had noticed on 13Mar2021 a rash on her upper left thigh that she had never seen before. She said she called her sister, who is a retired nurse, and her sister told her to call her doctor. She said she had a virtual visit with her doctor on Monday, and her doctor suggested she call Pfizer for further information about the COVID-19 Vaccine. She said her doctor said her rash looked like Shingles. The caller said her rash wasn't very painful. She said her rash was more bothersome than anything. She said her rash was itchy in the beginning with little blisters. She said after 5-6 days, the blisters flattened out. She said she still had marks on her legs from where the blisters were. She said her rash was not serious, and she did not have pain. She said the rash was just a bothersome discomfort. She said the rash cleared up quickly without her taking any antiviral medication. She said her doctor said her rash looked like a very mild case of Shingles. She said her doctor told her she didn't need to take anything, like an antiviral medication, for her rash, if she didn't want to. She said she chose not to take anything, and her rash cleared up on its own. She said she was scheduled for her second COVID-19 Vaccine dose on 01Apr2021, and she wanted to verify with Pfizer if she should get the second COVID-19 Vaccine based on her reaction to her first COVID-19 Vaccine dose. Caller was advised she would be transferred to Pfizer Medical Information for further assistance with her question. Caller stated compared to the alternative, getting the COVID-19 Virus, her rash was nothing. She said her sister was more concerned about her rash than her. She said her doctor said for her to follow-up with Pfizer to confirm it was OK for her to get the second COVID-19 Vaccine. Caller wanted to know if she should get the second COVID-19 Vaccine after having a Shingles rash after the first COVID-19 Vaccine. Outcome of the events was recovered.  Information on the lot/batch number has been Provided No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blister, Discomfort, Erythema, Herpes zoster, Rash
Clinical narrative: rash on her upper left thigh; doctor said her rash looked like Shingles; rash was itchy in the beginning with little blisters; rash was itchy in the beginning with little blisters; rash was just a bothersome discomfort; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 11Mar2021 (Batch/Lot Number: EN6206; Expiration Date: 30Mar2021) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient took her first COVID-19 Vaccine dose on 11Mar2021. She said she had noticed on 13Mar2021 a rash on her upper left thigh that she had never seen before. She said she called her sister, who is a retired nurse, and her sister told her to call her doctor. She said she had a virtual visit with her doctor on Monday, and her doctor suggested she call Pfizer for further information about the COVID-19 Vaccine. She said her doctor said her rash looked like Shingles. The caller said her rash wasn't very painful. She said her rash was more bothersome than anything. She said her rash was itchy in the beginning with little blisters. She said after 5-6 days, the blisters flattened out. She said she still had marks on her legs from where the blisters were. She said her rash was not serious, and she did not have pain. She said the rash was just a bothersome discomfort. She said the rash cleared up quickly without her taking any antiviral medication. She said her doctor said her rash looked like a very mild case of Shingles. She said her doctor told her she didn't need to take anything, like an antiviral medication, for her rash, if she didn't want to. She said she chose not to take anything, and her rash cleared up on its own. She said she was scheduled for her second COVID-19 Vaccine dose on 01Apr2021, and she wanted to verify with Pfizer if she should get the second COVID-19 Vaccine based on her reaction to her first COVID-19 Vaccine dose. Caller was advised she would be transferred to Pfizer Medical Information for further assistance with her question. Caller stated compared to the alternative, getting the COVID-19 Virus, her rash was nothing. She said her sister was more concerned about her rash than her. She said her doctor said for her to follow-up with Pfizer to confirm it was OK for her to get the second COVID-19 Vaccine. Caller wanted to know if she should get the second COVID-19 Vaccine after having a Shingles rash after the first COVID-19 Vaccine. Outcome of the events was recovered.  Information on the lot/batch number has been Provided No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Urticaria
Clinical narrative: developed a severe body rash over my entire body; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that the 62-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 10Mar2021 (Lot Number: EN6208) as SINGLE DOSE for covid-19 immunisation. Medical history included thyroid disorder from an unknown date and unknown if ongoing Other medical conditions: consumer stated, "No just thyroid." ( Further clarification unknown). Concomitant medication(s) included lurasidone hydrochloride (LATUDA) at 80 mg, once a day, oral for an unspecified indication, start and stop date were not reported; zolpidem tartrate (AMBIEN) at 6.25mg, once a day, oral for an unspecified indication, start and stop date were not reported; simvastatin (SIMVASTATIN) at 20mg, once a day, oral for an unspecified indication, start and stop date were not reported. The patient experienced developed a severe body rash over my entire body (hospitalization) on 16Mar2021 with outcome of unknown. Therapeutic measures were taken as a result of developed a severe body rash over my entire body. Reporter seriousness for have to go to the emergency room to get steroids to slow it down was Hospitalization. Consumer stated, "I had a reaction to the vaccine took vaccine ,I had it 6 days and I developed a severe body rash over my entire body." On paraphrasing concern: consumer stated, "This was the first shot, I had rash all over my body everywhere and I have to go to the emergency room to get steroids to slow it down, right, I am on Prednisone from 16March, I got shot on 10Mar and I got the reaction on 16Mar." Consumer stated, "That's what I want to report and do you know if have would have anything from having one shot my doctor won't let me take the second shot?" Consumer stated, "I have been on Prednisone since the 16th." ( Treatment in response to event), the Covid red rash, that's why they called me in hospital, when I went to hospital, I only I have this rash all over my body and it is slowly going away, I don't have thyroid I have rash all over my body."
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: developed a severe body rash over my entire body; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that the 62-year-old female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 10Mar2021 (Lot Number: EN6208) as SINGLE DOSE for covid-19 immunisation. Medical history included thyroid disorder from an unknown date and unknown if ongoing Other medical conditions: consumer stated, "No just thyroid." ( Further clarification unknown). Concomitant medication(s) included lurasidone hydrochloride (LATUDA) at 80 mg, once a day, oral for an unspecified indication, start and stop date were not reported; zolpidem tartrate (AMBIEN) at 6.25mg, once a day, oral for an unspecified indication, start and stop date were not reported; simvastatin (SIMVASTATIN) at 20mg, once a day, oral for an unspecified indication, start and stop date were not reported. The patient experienced developed a severe body rash over my entire body (hospitalization) on 16Mar2021 with outcome of unknown. Therapeutic measures were taken as a result of developed a severe body rash over my entire body. Reporter seriousness for have to go to the emergency room to get steroids to slow it down was Hospitalization. Consumer stated, "I had a reaction to the vaccine took vaccine ,I had it 6 days and I developed a severe body rash over my entire body." On paraphrasing concern: consumer stated, "This was the first shot, I had rash all over my body everywhere and I have to go to the emergency room to get steroids to slow it down, right, I am on Prednisone from 16March, I got shot on 10Mar and I got the reaction on 16Mar." Consumer stated, "That's what I want to report and do you know if have would have anything from having one shot my doctor won't let me take the second shot?" Consumer stated, "I have been on Prednisone since the 16th." ( Treatment in response to event), the Covid red rash, that's why they called me in hospital, when I went to hospital, I only I have this rash all over my body and it is slowly going away, I don't have thyroid I have rash all over my body."
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Throat tightness, Urticaria
Clinical narrative: Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; This is a spontaneous report from a contactable consumer (reporting for herself). A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 20Mar2021  (Batch/Lot Number: Ep-7534) as single dose for COVID-19 immunization. Medical history included seasonal allergy, asthma, and known allergies: penicillin. Concomitant medication included fexofenadine hydrochloride (ALLEGRA); montelukast sodium (SINGULAIR); amlodipine. all taken for an unspecified indication, start and stop date were not reported. The patient previously took grastek for immunomodulatory therapy and experienced drug allergy; bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En-6198) on 27Feb2021 for COVID-19 immunization. On unspecified date the patient experienced itching all over, coughing, asthma, anaphylaxis. The patient received 2 doses of epinephrine, 100 ml benedryl, and h1h2 bloc. The outcome of the events was recovering. The patient was not tested post vaccination and did not has COVID prior to vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Asthma, Cough, Pruritus
Clinical narrative: Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; Itching all over, coughing, asthma, anaphylaxis; This is a spontaneous report from a contactable consumer (reporting for herself). A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 20Mar2021  (Batch/Lot Number: Ep-7534) as single dose for COVID-19 immunization. Medical history included seasonal allergy, asthma, and known allergies: penicillin. Concomitant medication included fexofenadine hydrochloride (ALLEGRA); montelukast sodium (SINGULAIR); amlodipine. all taken for an unspecified indication, start and stop date were not reported. The patient previously took grastek for immunomodulatory therapy and experienced drug allergy; bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En-6198) on 27Feb2021 for COVID-19 immunization. On unspecified date the patient experienced itching all over, coughing, asthma, anaphylaxis. The patient received 2 doses of epinephrine, 100 ml benedryl, and h1h2 bloc. The outcome of the events was recovering. The patient was not tested post vaccination and did not has COVID prior to vaccination.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Pyrexia, Tinnitus
Clinical narrative: Pfizer 1st Shot gave me loud Tinnitus and hasn't stopped.; headache; Had fever for a few days; fatigued; arm soreness; he was scared; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 11:30 (Batch/Lot Number: EN6204) as SINGLE DOSE for covid-19 immunisation, age of vaccination 48 years old at workplace clinic. Medical history included Heart Disease and Covid-19 from an unknown date. No other vaccines in four weeks. Concomitant medication included losartan taken for an unspecified indication, start and stop date were not reported. The patient experienced loud tinnitus and hasn't stopped. Described as screaming High Pitch Ringing. Patient stated he was praying it will go away. Patient had headache, had fever for a few days, fatigued, and arm soreness on 19Mar2021 20:30 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): negative on 20Mar2021. Treatment was not received for tinnitus,  headache, had fever for a few days, fatigued, and arm soreness. Physician office visit was made for tinnitus, headache, had fever for a few days, fatigued, and arm soreness. The patient stated "This is really scary stuff. Please stop blaming it on Covid". Patient further stated, "Since day 2 of shot which I got on St Patty's Day 17Mar2021. I am on Day 13 of this new hell with no end in sight". He filed a VAERS report and notified his Primary care Dr and ENT. Patient won't get the 2nd shot, as he was scared (Mar2021)." Outcome of the event scared was unknown while not recovered for the other events. The patient considered the tinnitus as serious (very serious and others have experienced this).  No follow-up attempts are possible. No further information is expected. Lot number has been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366081 Same reporter/drug/AE, different patient;US-PFIZER INC-2021366082 Same reporter/drug/AE, different patient
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Nervousness, Pain in extremity, Pyrexia
Clinical narrative: Pfizer 1st Shot gave me loud Tinnitus and hasn't stopped.; headache; Had fever for a few days; fatigued; arm soreness; he was scared; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 11:30 (Batch/Lot Number: EN6204) as SINGLE DOSE for covid-19 immunisation, age of vaccination 48 years old at workplace clinic. Medical history included Heart Disease and Covid-19 from an unknown date. No other vaccines in four weeks. Concomitant medication included losartan taken for an unspecified indication, start and stop date were not reported. The patient experienced loud tinnitus and hasn't stopped. Described as screaming High Pitch Ringing. Patient stated he was praying it will go away. Patient had headache, had fever for a few days, fatigued, and arm soreness on 19Mar2021 20:30 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): negative on 20Mar2021. Treatment was not received for tinnitus,  headache, had fever for a few days, fatigued, and arm soreness. Physician office visit was made for tinnitus, headache, had fever for a few days, fatigued, and arm soreness. The patient stated "This is really scary stuff. Please stop blaming it on Covid". Patient further stated, "Since day 2 of shot which I got on St Patty's Day 17Mar2021. I am on Day 13 of this new hell with no end in sight". He filed a VAERS report and notified his Primary care Dr and ENT. Patient won't get the 2nd shot, as he was scared (Mar2021)." Outcome of the event scared was unknown while not recovered for the other events. The patient considered the tinnitus as serious (very serious and others have experienced this).  No follow-up attempts are possible. No further information is expected. Lot number has been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366081 Same reporter/drug/AE, different patient;US-PFIZER INC-2021366082 Same reporter/drug/AE, different patient
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Tinnitus
Clinical narrative: Pfizer 1st Shot gave me loud Tinnitus and hasn't stopped.; headache; Had fever for a few days; fatigued; arm soreness; he was scared; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 11:30 (Batch/Lot Number: EN6204) as SINGLE DOSE for covid-19 immunisation, age of vaccination 48 years old at workplace clinic. Medical history included Heart Disease and Covid-19 from an unknown date. No other vaccines in four weeks. Concomitant medication included losartan taken for an unspecified indication, start and stop date were not reported. The patient experienced loud tinnitus and hasn't stopped. Described as screaming High Pitch Ringing. Patient stated he was praying it will go away. Patient had headache, had fever for a few days, fatigued, and arm soreness on 19Mar2021 20:30 with outcome of not recovered. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab): negative on 20Mar2021. Treatment was not received for tinnitus,  headache, had fever for a few days, fatigued, and arm soreness. Physician office visit was made for tinnitus, headache, had fever for a few days, fatigued, and arm soreness. The patient stated "This is really scary stuff. Please stop blaming it on Covid". Patient further stated, "Since day 2 of shot which I got on St Patty's Day 17Mar2021. I am on Day 13 of this new hell with no end in sight". He filed a VAERS report and notified his Primary care Dr and ENT. Patient won't get the 2nd shot, as he was scared (Mar2021)." Outcome of the event scared was unknown while not recovered for the other events. The patient considered the tinnitus as serious (very serious and others have experienced this).  No follow-up attempts are possible. No further information is expected. Lot number has been obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366081 Same reporter/drug/AE, different patient;US-PFIZER INC-2021366082 Same reporter/drug/AE, different patient
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Sneezing
Clinical narrative: anaphylaxis; sneezing; throat swelling; Continued having breathing difficulty; coughing; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), (Batch/Lot Number: OCDPH) via an unspecified route of administration, administered in the left arm on 10Mar2021 16:15 (at the age of 49 years-old) as SINGLE DOSE for covid-19 immunisation.  Medical history included Crohn's Disease and chronic Migraines. Patient has allergies to medications, food, or other products such as Milk Protein and Compazine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medications included midodrine taken for an unspecified indication, start and stop date were not reported; and rizatriptan benzoate (MAXALT) taken for an unspecified indication, start and stop date were not reported. On 10Mar2021 16:30 (as reported), patient was sneezing within 5-10 minutes of receiving dose, had anaphylaxis within 15-20 minutes of receiving dose. She continued having breathing difficulty, sneezing, coughing and throat swelling for 5 days which was treated with Benadryl. Second dose of Epipen was required 20 hrs. later and continued use of Benadryl, Allegra and inhaler for 4-6 days. Continued issues with over stimulation of allergic reaction to other known allergies continues. The outcome of events was reported as recovered with sequelae. The events required emergency room and physician's office visit. Therapeutic measures taken as a result of the events included EpiPen, Steroid, Benadryl and inhaler (unspecified). The events were assessed as serious, life threatening illness (immediate risk of death from the event).  Follow-up attempts are completed. The information on the batch/lot number has already been obtained.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Cough, Dyspnoea, Pharyngeal swelling, Sneezing
Clinical narrative: anaphylaxis; sneezing; throat swelling; Continued having breathing difficulty; coughing; This is a spontaneous report from a contactable consumer (patient).  A 49-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), (Batch/Lot Number: OCDPH) via an unspecified route of administration, administered in the left arm on 10Mar2021 16:15 (at the age of 49 years-old) as SINGLE DOSE for covid-19 immunisation.  Medical history included Crohn's Disease and chronic Migraines. Patient has allergies to medications, food, or other products such as Milk Protein and Compazine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medications included midodrine taken for an unspecified indication, start and stop date were not reported; and rizatriptan benzoate (MAXALT) taken for an unspecified indication, start and stop date were not reported. On 10Mar2021 16:30 (as reported), patient was sneezing within 5-10 minutes of receiving dose, had anaphylaxis within 15-20 minutes of receiving dose. She continued having breathing difficulty, sneezing, coughing and throat swelling for 5 days which was treated with Benadryl. Second dose of Epipen was required 20 hrs. later and continued use of Benadryl, Allegra and inhaler for 4-6 days. Continued issues with over stimulation of allergic reaction to other known allergies continues. The outcome of events was reported as recovered with sequelae. The events required emergency room and physician's office visit. Therapeutic measures taken as a result of the events included EpiPen, Steroid, Benadryl and inhaler (unspecified). The events were assessed as serious, life threatening illness (immediate risk of death from the event).  Follow-up attempts are completed. The information on the batch/lot number has already been obtained.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Myalgia, Nausea
Clinical narrative: admitted to ER Saturday morning with massive heart attack; feeling unwell Friday evening; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Batch/Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in Arm Left on 26Mar2021 13:30 (at the age of 68years) as single dose for Covid-19 immunization. The patient received the first dose of BNT162B2 (lot number: EN6200) on 02Mar2021 (at the age of 68years) for Covid-19 immunization. The patient's medical history was not reported, no known allergies. Concomitant medications included rosuvastatin taken for an unspecified indication, start and stop date were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the patient was feeling unwell on Friday evening (as reported); patient admitted to ER (emergency room) Saturday morning with massive heart attack. Onset date for both events was reported as 26Mar2021 21:45. The events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. The patient was hospitalized for both events from 27Mar2021 to 01Apr2021 (as reported duration of hospitalization: for 5 days). Treatment of events included 2 Stents. The patient had Covid test post vaccination on an unspecified date: Nasal Swab =Negative. The outcome of events was recovering. The outcome of events was recovering.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Myocardial infarction, SARS-CoV-2 test
Clinical narrative: admitted to ER Saturday morning with massive heart attack; feeling unwell Friday evening; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Batch/Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in Arm Left on 26Mar2021 13:30 (at the age of 68years) as single dose for Covid-19 immunization. The patient received the first dose of BNT162B2 (lot number: EN6200) on 02Mar2021 (at the age of 68years) for Covid-19 immunization. The patient's medical history was not reported, no known allergies. Concomitant medications included rosuvastatin taken for an unspecified indication, start and stop date were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the patient was feeling unwell on Friday evening (as reported); patient admitted to ER (emergency room) Saturday morning with massive heart attack. Onset date for both events was reported as 26Mar2021 21:45. The events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. The patient was hospitalized for both events from 27Mar2021 to 01Apr2021 (as reported duration of hospitalization: for 5 days). Treatment of events included 2 Stents. The patient had Covid test post vaccination on an unspecified date: Nasal Swab =Negative. The outcome of events was recovering. The outcome of events was recovering.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dyspnoea, Pruritus, Tremor
Clinical narrative: throat has been itching; having a hard time breathing; everything hurts and feels like she got hit by a truck; bad allergic reaction; throat started closing up; throat has felt swollen; wheezing; a rash on and off located around her throat and chest.; her symptoms began at the vaccination site; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EP8720), via an unspecified route of administration in left arm on 27Mar2021 11:00 (at the age of 29-years-old) as single dose for covid-19 immunisation. The vaccination facility type was a pharmacy/drug store and vaccine was not administered at military facility. Medical history included asthma and pulmonary embolism, both ongoing. There were no family medical history relevant to the events. No AE(s) following prior vaccinations. No Prior Vaccinations (within 4 weeks). The patient had no investigation assessment. Concomitant medications included apixaban (ELIQUIS) from an unspecified start date and ongoing for pulmonary embolism and prednisone for asthma from 31Jan2021 and ongoing. The patient received the first dose of BNT162B2 on this past Saturday (on 27Mar2021) and she had a bad allergic reaction and she has been having allergic reaction symptoms since then, almost in anaphylactic shock, throat has felt swollen, she has been wheezing, a rash on and off located around her throat and chest and throat started closing up, all on 27Mar2021 at 11:08. The patient stated her symptoms began at the vaccination site and she was taken by ambulance to an emergency room for treatment. On 28Mar2021, another allergic reaction; wheezing and her throat started closing up and she had a rash around her neck. On 31Mar2021, the patient was having allergic reactions, throat has been itching, having a hard time breathing, and everything hurts and feels like she got hit by a truck. The patient had the shot on Saturday 27Mar2021 and within eight minutes she was almost in anaphylactic shock. The patient got that taken care of and the next day she went into another allergic reaction and now today she was still having allergic reactions. The patient considered the events as non-serious. The patient would like to know how long her symptoms would last. Called ambulance with treatments included 2 shots of Epi and IV steroids and diphenhydramine hydrochloride (BENADRYL) and nebulizer treatments. The patient had anaphylactic reactions with allergy shots. The events required emergency room visits on 27Mar2021 and on 28Mar2021. No physician office visit. The outcome was recovered for anaphylactic shock, rash and wheezing on 27Mar2021; unknown for vaccination site reaction and not recovered for the remaining events.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Hypersensitivity, Pain, Pharyngeal swelling, Rash
Clinical narrative: throat has been itching; having a hard time breathing; everything hurts and feels like she got hit by a truck; bad allergic reaction; throat started closing up; throat has felt swollen; wheezing; a rash on and off located around her throat and chest.; her symptoms began at the vaccination site; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EP8720), via an unspecified route of administration in left arm on 27Mar2021 11:00 (at the age of 29-years-old) as single dose for covid-19 immunisation. The vaccination facility type was a pharmacy/drug store and vaccine was not administered at military facility. Medical history included asthma and pulmonary embolism, both ongoing. There were no family medical history relevant to the events. No AE(s) following prior vaccinations. No Prior Vaccinations (within 4 weeks). The patient had no investigation assessment. Concomitant medications included apixaban (ELIQUIS) from an unspecified start date and ongoing for pulmonary embolism and prednisone for asthma from 31Jan2021 and ongoing. The patient received the first dose of BNT162B2 on this past Saturday (on 27Mar2021) and she had a bad allergic reaction and she has been having allergic reaction symptoms since then, almost in anaphylactic shock, throat has felt swollen, she has been wheezing, a rash on and off located around her throat and chest and throat started closing up, all on 27Mar2021 at 11:08. The patient stated her symptoms began at the vaccination site and she was taken by ambulance to an emergency room for treatment. On 28Mar2021, another allergic reaction; wheezing and her throat started closing up and she had a rash around her neck. On 31Mar2021, the patient was having allergic reactions, throat has been itching, having a hard time breathing, and everything hurts and feels like she got hit by a truck. The patient had the shot on Saturday 27Mar2021 and within eight minutes she was almost in anaphylactic shock. The patient got that taken care of and the next day she went into another allergic reaction and now today she was still having allergic reactions. The patient considered the events as non-serious. The patient would like to know how long her symptoms would last. Called ambulance with treatments included 2 shots of Epi and IV steroids and diphenhydramine hydrochloride (BENADRYL) and nebulizer treatments. The patient had anaphylactic reactions with allergy shots. The events required emergency room visits on 27Mar2021 and on 28Mar2021. No physician office visit. The outcome was recovered for anaphylactic shock, rash and wheezing on 27Mar2021; unknown for vaccination site reaction and not recovered for the remaining events.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Throat irritation, Throat tightness, Vaccination site reaction, Wheezing
Clinical narrative: throat has been itching; having a hard time breathing; everything hurts and feels like she got hit by a truck; bad allergic reaction; throat started closing up; throat has felt swollen; wheezing; a rash on and off located around her throat and chest.; her symptoms began at the vaccination site; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EP8720), via an unspecified route of administration in left arm on 27Mar2021 11:00 (at the age of 29-years-old) as single dose for covid-19 immunisation. The vaccination facility type was a pharmacy/drug store and vaccine was not administered at military facility. Medical history included asthma and pulmonary embolism, both ongoing. There were no family medical history relevant to the events. No AE(s) following prior vaccinations. No Prior Vaccinations (within 4 weeks). The patient had no investigation assessment. Concomitant medications included apixaban (ELIQUIS) from an unspecified start date and ongoing for pulmonary embolism and prednisone for asthma from 31Jan2021 and ongoing. The patient received the first dose of BNT162B2 on this past Saturday (on 27Mar2021) and she had a bad allergic reaction and she has been having allergic reaction symptoms since then, almost in anaphylactic shock, throat has felt swollen, she has been wheezing, a rash on and off located around her throat and chest and throat started closing up, all on 27Mar2021 at 11:08. The patient stated her symptoms began at the vaccination site and she was taken by ambulance to an emergency room for treatment. On 28Mar2021, another allergic reaction; wheezing and her throat started closing up and she had a rash around her neck. On 31Mar2021, the patient was having allergic reactions, throat has been itching, having a hard time breathing, and everything hurts and feels like she got hit by a truck. The patient had the shot on Saturday 27Mar2021 and within eight minutes she was almost in anaphylactic shock. The patient got that taken care of and the next day she went into another allergic reaction and now today she was still having allergic reactions. The patient considered the events as non-serious. The patient would like to know how long her symptoms would last. Called ambulance with treatments included 2 shots of Epi and IV steroids and diphenhydramine hydrochloride (BENADRYL) and nebulizer treatments. The patient had anaphylactic reactions with allergy shots. The events required emergency room visits on 27Mar2021 and on 28Mar2021. No physician office visit. The outcome was recovered for anaphylactic shock, rash and wheezing on 27Mar2021; unknown for vaccination site reaction and not recovered for the remaining events.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Erythema, Throat irritation
Clinical narrative: throat has been itching; having a hard time breathing; everything hurts and feels like she got hit by a truck; bad allergic reaction; throat started closing up; throat has felt swollen; wheezing; a rash on and off located around her throat and chest.; her symptoms began at the vaccination site; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EP8720), via an unspecified route of administration in left arm on 27Mar2021 11:00 (at the age of 29-years-old) as single dose for covid-19 immunisation. The vaccination facility type was a pharmacy/drug store and vaccine was not administered at military facility. Medical history included asthma and pulmonary embolism, both ongoing. There were no family medical history relevant to the events. No AE(s) following prior vaccinations. No Prior Vaccinations (within 4 weeks). The patient had no investigation assessment. Concomitant medications included apixaban (ELIQUIS) from an unspecified start date and ongoing for pulmonary embolism and prednisone for asthma from 31Jan2021 and ongoing. The patient received the first dose of BNT162B2 on this past Saturday (on 27Mar2021) and she had a bad allergic reaction and she has been having allergic reaction symptoms since then, almost in anaphylactic shock, throat has felt swollen, she has been wheezing, a rash on and off located around her throat and chest and throat started closing up, all on 27Mar2021 at 11:08. The patient stated her symptoms began at the vaccination site and she was taken by ambulance to an emergency room for treatment. On 28Mar2021, another allergic reaction; wheezing and her throat started closing up and she had a rash around her neck. On 31Mar2021, the patient was having allergic reactions, throat has been itching, having a hard time breathing, and everything hurts and feels like she got hit by a truck. The patient had the shot on Saturday 27Mar2021 and within eight minutes she was almost in anaphylactic shock. The patient got that taken care of and the next day she went into another allergic reaction and now today she was still having allergic reactions. The patient considered the events as non-serious. The patient would like to know how long her symptoms would last. Called ambulance with treatments included 2 shots of Epi and IV steroids and diphenhydramine hydrochloride (BENADRYL) and nebulizer treatments. The patient had anaphylactic reactions with allergy shots. The events required emergency room visits on 27Mar2021 and on 28Mar2021. No physician office visit. The outcome was recovered for anaphylactic shock, rash and wheezing on 27Mar2021; unknown for vaccination site reaction and not recovered for the remaining events.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersomnia, Lymphadenopathy, Pain, Pain in extremity, Pyrexia
Clinical narrative: flu like symptoms; Fever/low grade fever at night; body aches; excessive sleeping; vaccine arm enlarged lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 68-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6200), via an unspecified route of administration in left arm on 18Feb2021 11:30 (68-years-old at the time of vaccination), as single dose for covid-19 immunization. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL9263), via an unspecified route of administration in left arm on 28Jan2021 11:30, as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered:Public Health Clinic Administration facility. Medical history included chronic lymphocytic leukaemia. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 11:30, the patient experienced flu like symptoms, fever/low grade fever at night, body aches, excessive sleeping and vaccine arm enlarged lymph nodes. Did the adverse event result in any of the following?: Doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the adverse events. Since the vaccination, the patient was not tested for COVID-19. The outcome of events was recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersomnia, Influenza like illness, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: flu like symptoms; Fever/low grade fever at night; body aches; excessive sleeping; vaccine arm enlarged lymph nodes; This is a spontaneous report received from a contactable consumer (patient). A 68-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6200), via an unspecified route of administration in left arm on 18Feb2021 11:30 (68-years-old at the time of vaccination), as single dose for covid-19 immunization. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL9263), via an unspecified route of administration in left arm on 28Jan2021 11:30, as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered:Public Health Clinic Administration facility. Medical history included chronic lymphocytic leukaemia. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Feb2021 at 11:30, the patient experienced flu like symptoms, fever/low grade fever at night, body aches, excessive sleeping and vaccine arm enlarged lymph nodes. Did the adverse event result in any of the following?: Doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the adverse events. Since the vaccination, the patient was not tested for COVID-19. The outcome of events was recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Eye pain, Headache, Implant site pain, Myalgia
Clinical narrative: fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; This is a spontaneous report from a contactable consumer. A 57-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 26Mar2021 18:30 (Batch/Lot Number: ER8732) as single dose for covid-19 immunisation. Medical history included, Biaxin allergies. Concomitant medication(s) included vitamin d3 (VITAMIN D3). The patient previously took bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: EN6199), dose 1 via an unspecified route of administration, administered in Arm Right on 26Mar2021 18:30 as single dose for COVID-19 immunization. The patient experienced fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts 27Mar2021 10:15. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. No treatment was received for the events. The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; This is a spontaneous report from a contactable consumer. A 57-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 26Mar2021 18:30 (Batch/Lot Number: ER8732) as single dose for covid-19 immunisation. Medical history included, Biaxin allergies. Concomitant medication(s) included vitamin d3 (VITAMIN D3). The patient previously took bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: EN6199), dose 1 via an unspecified route of administration, administered in Arm Right on 26Mar2021 18:30 as single dose for COVID-19 immunization. The patient experienced fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts 27Mar2021 10:15. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. No treatment was received for the events. The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dental discomfort, Eye pain, Headache, Pain
Clinical narrative: fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts; This is a spontaneous report from a contactable consumer. A 57-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 26Mar2021 18:30 (Batch/Lot Number: ER8732) as single dose for covid-19 immunisation. Medical history included, Biaxin allergies. Concomitant medication(s) included vitamin d3 (VITAMIN D3). The patient previously took bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: EN6199), dose 1 via an unspecified route of administration, administered in Arm Right on 26Mar2021 18:30 as single dose for COVID-19 immunization. The patient experienced fever, chills, headache, eyes hurt, location of dental implant hurt, body hurts 27Mar2021 10:15. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. No treatment was received for the events. The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.